Reply: Mutations in NPC1L1 and coronary heart disease

New England Journal of Medicine

Volumn 372, Issue 9, 2015, Pages 881-882

  Weingärtner, Oliver ^a   Lütjohann, Dieter ^b   Patel, Shailendra B ^c  

^a European Medical School Oldenburg Groningen   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYPHYTOSTEROL; OXYSTEROL; UNCLASSIFIED DRUG; MEMBRANE PROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; FOOD COMPOSITION; GENE; GENE MUTATION; HEART INFARCTION; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; NPC1L1 GENE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GENE SILENCING; GENETICS; MALE; MUTATION;

CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENE SILENCING; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION;

EID: 84923826217     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1500124     Document Type: Letter

References (4)

1. Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012;60:2631-9.
2. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78. [Errata, Lancet 2005;366:1358, 2008; 371:2084.]
3. Weingärtner O, Lütjohann D, Ji S, et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008; 51:1553-61.
4. Patel SB, Salen G. Sitosterolemia: xenophobia for the body: In: Vissers MN, Kastelein JJP, Stroes ES, eds. Evidence-based management of lipid disorders. Harley, United Kingdom: tfm Publishing, 2010:217-30.